ImportRefusal LogoImportRefusal

Xenex Laboratories Inc.

⚠️ Moderate Risk

FEI: 3007170694 • Coquitlam, British Columbia • CANADA

FEI

FEI Number

3007170694

📍

Location

Coquitlam, British Columbia

🇨🇦

Country

CANADA
🏢

Address

2440 Canoe Ave Unit 102, , Coquitlam, British Columbia, Canada

Moderate Risk

FDA Import Risk Assessment

49.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

11
Total Refusals
2
Unique Violations
7/2/2025
Latest Refusal
3/22/2006
Earliest Refusal

Score Breakdown

Violation Severity
53.6×40%
Refusal Volume
40.0×30%
Recency
75.3×20%
Frequency
5.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

11810×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
7/2/2025
62MBJ08MENTHOL (ANTI-PRURITIC)
118NOT LISTED
Division of Southeast Imports (DSEI)
8/5/2011
55RP99PHARMACEUTIC NECESSITIES, N.E.C.
118NOT LISTED
New Orleans District Office (NOL-DO)
2/5/2007
66VCS99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
Seattle District Office (SEA-DO)
8/29/2006
62GCB41IBUPROFEN (ANTI-INFLAMMATORY)
118NOT LISTED
Seattle District Office (SEA-DO)
8/29/2006
65JCS31PROGESTERONE (PROGESTIN)
118NOT LISTED
Seattle District Office (SEA-DO)
8/29/2006
62GDY18DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
118NOT LISTED
Seattle District Office (SEA-DO)
8/29/2006
62CAY41MINOXIDIL (ANTI-HYPERTENSIVE)
118NOT LISTED
Seattle District Office (SEA-DO)
8/29/2006
56JIS22CLINDAMYCIN PHOSPHATE (LINCOMYCINS)
118NOT LISTED
Seattle District Office (SEA-DO)
8/29/2006
64LAS38HYDROCORTISONE ACETATE (GLUCOCORTICOID)
118NOT LISTED
Seattle District Office (SEA-DO)
8/29/2006
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
Seattle District Office (SEA-DO)
3/22/2006
60GRS01DISULFIRAM (ALCOHOL DETERRENT)
75UNAPPROVED
Seattle District Office (SEA-DO)

Frequently Asked Questions

What is Xenex Laboratories Inc.'s FDA import refusal history?

Xenex Laboratories Inc. (FEI: 3007170694) has 11 FDA import refusal record(s) in our database, spanning from 3/22/2006 to 7/2/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Xenex Laboratories Inc.'s FEI number is 3007170694.

What types of violations has Xenex Laboratories Inc. received?

Xenex Laboratories Inc. has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Xenex Laboratories Inc. come from?

All FDA import refusal data for Xenex Laboratories Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.